Speaker Details

Gil Yosipovitch, MD

Gil Yosipovitch, MD

SESSIONS

S002 Chronic Pruritus: Bedside to Bench Perspectives
Mar 7, 2025 9:00 AM - 12:00 PM W311G
U019 Prurigo Nodularis
Mar 7, 2025 3:30 PM - 4:30 PM W308A
F058 Itch
Mar 9, 2025 1:00 PM - 3:00 PM Valencia Ballroom B
F083 Chronic Urticaria: What's New
Mar 10, 2025 9:00 AM - 11:00 AM W207A

DISCLOSURES

AbbVie – Advisory Board(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria); Cara Therapeutics – Advisory Board(Honoraria); CeraVe – Advisory Board(Honoraria); Eli Lilly – Investigator(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria); escient – Investigator(Fees), Investigator(Grants/Research Funding); Galderma – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); GSK – Advisory Board(Honoraria); Kamari Pharma – Consultant(Fees); Kiniksa Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Maruho Co., Ltd – Speaker/Faculty Education(Fees); Novartis – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pierre Fabre – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Vifor Pharma – Consultant(Fees);